Motley Fool Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Motley Fool Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,630	Closed	-$208K	–	245
2025 Q4	$208K	Buy	+2,630	New	+$198K	0.01%	236
2022 Q1	–	Sell	-66	Closed	-$2K	–	268
2021 Q4	$2K	Buy	+66	New	+$2.08K	﹤0.01%	284
2019 Q2	–	Sell	-127,457	Closed	-$10.3M	–	173
2019 Q1	$10.3M	Buy	127,457 +6,340	+5%	+$409K	1.2%	28
2018 Q4	$6.55M	Buy	121,117 +32,017	+36%	+$1.63M	0.92%	43
2018 Q3	$4.6M	Hold	89,100	–	–	0.56%	54
2018 Q2	$3.71M	Sell	89,100 -195,000	-69%	-$8.64M	0.5%	56
2018 Q1	$12.5M	Buy	284,100 +25,000	+10%	+$1.27M	1.76%	19
2017 Q4	$13M	Buy	259,100 +100	+0%	+$5.48K	2.82%	11
2017 Q3	$13.1M	Hold	259,000	–	–	2.63%	10
2017 Q2	$13.2M	Hold	259,000	–	–	2.73%	9
2017 Q1	$10.4M	Hold	259,000	–	–	2.25%	16
2016 Q4	$12.4M	Hold	259,000	–	–	2.75%	7
2016 Q3	$9.49M	Buy	+259,000	New	+$8.1M	2.09%	15
2016 Q2	–	Sell	-140,000	Closed	-$5.67M	–	77
2016 Q1	$5.67M	Buy	140,000 +120,000	+600%	+$4.87M	1.19%	37
2015 Q4	$1.86M	Buy	+20,000	New	+$1.08M	0.37%	69

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Motley Fool Asset Management's IONS Position: Q1 2026 in Review

Motley Fool Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 2,630 shares — an estimated $208K sold.

Motley Fool Asset Management first reported a position in IONS in Q4 2015 and held it in 15 quarters. The position peaked at $13.2M in Q2 2017. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Motley Fool Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Motley Fool Asset Management sold 2,630 Ionis Pharmaceuticals shares in Q1 2026, an estimated $208K.
Motley Fool Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 15 quarters.
Motley Fool Asset Management's Ionis Pharmaceuticals position peaked at $13.2M in Q2 2017.
494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Motley Fool Asset Management's 13F filing for Q1 2026, filed 12 May 2026.